blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3676271

EP3676271 - THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME [Right-click to bookmark this link]
Former [2020/28]THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING SAME
[2023/35]
StatusExamination is in progress
Status updated on  16.03.2023
Database last updated on 31.08.2024
FormerRequest for examination was made
Status updated on  05.06.2020
FormerThe international publication has been made
Status updated on  08.03.2019
Formerunknown
Status updated on  08.10.2018
Most recent event   Tooltip29.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Oregon State University
Office for Commercialization & Corporate
Development
A312 Kerr Administration Building
Corvallis, OR 97331-2140 / US
[2020/28]
Inventor(s)01 / BEAUDRY, Chris
Office For Commercialization&Corporate
Development
A312 Kerr Administration Building
Corvallis OR 97331-2140 / US
02 / HURST, James
Office For Commercialization&Corporate
Development
A312 Kerr Administration Building
Corvallis OR 97331-2140 / US
03 / BECKMAN, Joseph
Office For Commercialization&Corporate
Development
A312 Kerr Administration Building
Corvallis OR 97331-2140 / US
04 / SIROIS, John
Office For Commercialization&Corporate
Development
A312 Kerr Administration Building
Corvallis OR 97331-2140 / US
 [2020/28]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2020/28]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date18778677.731.08.2018
[2020/28]
WO2018US49163
Priority number, dateUS201762553714P01.09.2017         Original published format: US 201762553714 P
[2020/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019046761
Date:07.03.2019
Language:EN
[2019/10]
Type: A1 Application with search report 
No.:EP3676271
Date:08.07.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 07.03.2019 takes the place of the publication of the European patent application.
[2020/28]
Search report(s)International search report - published on:EP07.03.2019
ClassificationIPC:C07F1/08, A61P25/14, A61K33/34
[2020/28]
CPC:
C07F1/005 (EP); A61K33/34 (EP,US); A61K31/155 (US);
A61K31/4152 (EP); A61K31/428 (EP); A61K31/4545 (US);
A61K45/06 (US); C07F1/08 (US) (-)
C-Set:
A61K31/4152, A61K2300/00 (EP);
A61K31/428, A61K2300/00 (EP);
A61K33/34, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/28]
TitleGerman:THERAPEUTISCHE METALLKOMPLEXE UND LIGANDEN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON[2020/28]
English:THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME[2023/35]
French:COMPLEXES DE MÉTAL THÉRAPEUTIQUES ET LIGANDS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION[2020/28]
Former [2020/28]THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING SAME
Entry into regional phase05.03.2020National basic fee paid 
05.03.2020Designation fee(s) paid 
05.03.2020Examination fee paid 
Examination procedure05.03.2020Examination requested  [2020/28]
05.03.2020Date on which the examining division has become responsible
12.11.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
20.01.2021Amendment by applicant (claims and/or description)
15.03.2023Despatch of a communication from the examining division (Time limit: M04)
24.07.2023Reply to a communication from the examining division
Request for further processing for:20.01.2021Request for further processing filed
20.01.2021Full payment received (date of receipt of payment)
Request granted
29.01.2021Decision despatched
Fees paidRenewal fee
13.08.2020Renewal fee patent year 03
13.08.2021Renewal fee patent year 04
18.07.2022Renewal fee patent year 05
27.07.2023Renewal fee patent year 06
29.07.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2008061306  (UNIV MELBOURNE [AU], et al) [X] 1,19,20 * claims 1,91 * [I] 2-18,21-33;
 [XI]WO2015070177  (COLLABORATIVE MEDICINAL DEV LLC [US]) [X] 1,19,20 * claims 1,6,13,15 * [I] 2-18,31-33;
 [XA]WO2017070752  (UNIV QUEENSLAND [AU]) [X] 1,19 * page 24; claims 1,17,24 * [A] 2-18,20-33;
 [XP]WO2017214546  (UNIV LOUISVILLE RES FOUND INC [US]) [XP] 1* claims 1,11 *;
 [X]  - ZDENA DURACKOVÁ ET AL, "Thiohydrazone copper(II) complexes. The relationship between redox properties and superoxide dismutase mimetic activity", BIOELECTROCHEMISTRY AND BIOENERGETICS., XX, (19990201), vol. 48, no. 1, doi:10.1016/S0302-4598(98)00231-1, ISSN 0302-4598, pages 109 - 116, XP055522960 [X] 1,19 * figure 2; tables 1,3 *

DOI:   http://dx.doi.org/10.1016/S0302-4598(98)00231-1
 [X]  - DEARLING J L J ET AL, "Redox-active metal complexes for imaging hypoxic tissues: Structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes", CHEMICAL COMMUNICATIONS, ROYAL SOCIETY OF CHEMISTRY, (19981121), vol. 4, no. 22, doi:10.1039/A805957H, ISSN 1359-7345, pages 2531 - 2532, XP002405152 [X] 1,19 * abstract * * page 2531, column r, line 1 - line 25 *

DOI:   http://dx.doi.org/10.1039/a805957h
 [X]  - EUGENE A. COATS ET AL, "Comparative analysis of the cytotoxicity of substituted [phenylglyoxal bis(4-methyl-3-thiosemicarbazone]copper(II) chelates", JOURNAL OF MEDICINAL CHEMISTRY, (19760101), vol. 19, no. 1, doi:10.1021/jm00223a023, ISSN 0022-2623, pages 131 - 135, XP055522818 [X] 1,2,4,9,19 * abstract * * tables I,III *

DOI:   http://dx.doi.org/10.1021/jm00223a023
 [X]  - EUGENE A. COATS ET AL, "Comparative analysis of the cytotoxicity of substituted [phenylglyoxal bis(4-methyl-3-thiosemicarbazone)]copper(II) chelates. 2. Parabolic correlations and their implications for selective toxicity", JOURNAL OF MEDICINAL CHEMISTRY, (19780801), vol. 21, no. 8, doi:10.1021/jm00206a017, ISSN 0022-2623, pages 804 - 809, XP055030125 [X] 1,4,9,19 * abstract * * tables I-III *

DOI:   http://dx.doi.org/10.1021/jm00206a017
 [X]  - LARRY E. WARREN ET AL, "The mass spectra of some copper(II) complexes related to anti-carcinogens", OMS. ORGANIC MASS SPECTROMETRY., GB, (19710101), vol. 5, no. 1, doi:10.1002/oms.1210050103, ISSN 0030-493X, pages 15 - 18, XP055523014 [X] 1,2,8,19 * abstract * * Scheme 3 *

DOI:   http://dx.doi.org/10.1002/oms.1210050103
by applicant   - S. M. BERGE, "Pharmaceutical Salts", J. Pharm. Sci., (19770000), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560

DOI:   http://dx.doi.org/10.1002/jps.2600660104
    - "Pro-drugs as Novel Delivery Systems", T. HIGUCHI; V. STELLA, A.C.S. Symposium Series, and in Bioreversible Carriers in Drug Design, American Pharmaceutical Association and Pergamon Press, (19870000), vol. 14
    - HARTWIG, S., Polym. Chem., (20100000), vol. 1, pages 69 - 71
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.